Real-life experience with a generic formulation of Elexacaftor/Tezacaftor/ Ivacaftor in patients with Cystic Fibrosis with responsive CFTR variants without previous modulators therapy - Vienna 2024

New opportunities and challenges in the management of cystic fibrosis

Chair(s): B?lent Taner Karadag, Eleana Kouroukli

Session type: Poster session

Real-life experience with a generic formulation of Elexacaftor/Tezacaftor/ Ivacaftor in patients with Cystic Fibrosis with responsive CFTR variants without previous modulators therapy

Alejandro Teper

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Enhancing Parental Knowledge of Cystic Fibrosis Through Education

Mine Y?ksel Kalyoncu

Poster

Abstract

The effect of telemonitoring in preventing lung function decline in cystic fibrosis

Elpis Hatziagorou

Poster

Abstract

Prompt effect of ELX/TEZ/IVA on the lung function in patients with cystic fibrosis in North Macedonia

Elena Krsteska

Poster

Abstract

Evaluation of social determinants of health in people with cystic fibrosis living at the affected areas of devastating earthquake in Turkey: multicenter-study

Seyda Karabulut

Poster

Abstract

Social determinants of health in Cystic Fibrosis

Seyda Karabulut

Poster

Abstract

Comprehensive genetic and clinical profiling of people with cystic fibrosis ineligible for CFTR modulator therapy: Insights from a diverse patient cohort

Ceren Ay?a Yildiz

Poster

Abstract

Demographic and anthropometric changes of patients with cystic fibrosis by years, relationship between variables and survival analysis

Seyda Karabulut

Poster

Abstract

Real-life experience with a generic formulation of Elexacaftor/Tezacaftor/ Ivacaftor in patients with Cystic Fibrosis with responsive CFTR variants without previous modulators therapy

Alejandro Teper

Poster

Abstract

Evaluating the efficacy of IRT-based newborn screening for cystic fibrosis in a Turkish tertiary care center

Cigdem Korkmaz

Poster

Abstract

Follow-up of a cohort of patients with cystic fibrosis in therapy with Elexacaftor-Tezacaftor-Ivacaftor

Arturo Penco

Poster

Abstract

The relationship between infant and preschool lung function in cystic fibrosis. A pilot follow-up study.

V?clav Kouck?

Poster

Abstract

Prospective study of oral health in children and adults with cystic fibrosis (CF)

Marianne Muhlebach

Poster

Abstract

Lung ultrasound correlation with chronic inflammation in CF lung disease

Diana Popin

Abstract

Evaluation of Predictive Biomarkers for Pulmonary Exacerbations in Cystic Fibrosis

Ayse Tana Aslan

Poster

Abstract

Cystic Fibrosis in Turkiye: Ministry of Health Data

Tu?ba ?i?manlar Eyuboglu

Poster

Abstract

Triple modulator therapy effects in children and young adults with cystic fibrosis

Elvira Rizza

Poster

Abstract

Optimizing nutritional strategies for cystic fibrosis pediatric patients ineligible for CFTR modulators

Ibtehal Al-harbi

Poster

Abstract

Effect of Elexacaftor/tezacaftor/ivacaftor on allergic bronchopulmonary aspergillosis in a paediatric cystic fibrosis population

Magdalena Smolkova

Poster

Abstract

Clusters of lung clearance index trajectories and survival in people with cystic fibrosis

Anja Maria Schaffer

Poster

Abstract

Declining trend in chronic Staphylococcus aureus and Pseudomonas aeruginosa infections in CF patients: A 4-year retrospective analysis

Andrijana Andreevska Stepanovska

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}